Kaye Mark
SEC CIK 1748691 · EDGAR
BoughtSold
Most active insiders at CNMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Garner Todd W | EVP, CFO | — | $150.5K |
| 2 | Glaze Richard | CIO | — | $10.6K |
| 3 | Foust Hollie K | GC, Corp Sec | — | — |
| 4 | Lalomia Brent | Executive VP RA, QA | — | — |
| 5 | Council LaVerne H | Dir | — | — |
| 6 | Schwarzentraub Barbara J | Dir | — | — |
| 7 | Kaye Mark | Dir | — | — |
| 8 | Kelderman Kim | Dir | — | — |
| 9 | Farkas Charles | Dir | — | — |
| 10 | Bronson David M. | Dir | — | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-03 16:10 | 2026-06-02 | CNMD | CONMED Corp | Kaye Mark | Dir | M - OptEx | $0.00 | +668 | 820 | +439% | $0 |
| DM | 2026-03-04 | 2026-03-02+ | ELV | Elevance Health | Kaye Mark | EVP, CFO | F - Tax | $288.39 | -624 | 15.8K | -4% | -$180.0K |
| DM | 2026-03-04 | 2026-03-02 | ELV | Elevance Health | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +16.6K | 22.2K | +296% | $0 |
| D | 2026-02-26 | 2026-02-24 | CNMD | CONMED Corp | Kaye Mark | Dir | M - OptEx | $0.00 | +152 | 152 | New | $0 |
| 2025-10-03 | 2025-10-02 | ELV | Elevance Health | Kaye Mark | EVP, CFO | F - Tax | $340.24 | -2,895 | 16.1K | -15% | -$985.0K | |
| 2025-04-25 | 2025-04-24 | ELV | Elevance Health | Kaye Mark | EVP, CFO | S - Sale | $424.82 | -4,588 | 19.0K | -19% | -$1.95M | |
| D | 2025-03-05 | 2025-03-03 | ELV | Elevance Health | Kaye Mark | EVP, CFO | F - Tax | $395.50 | -270 | 20.0K | -1% | -$106.8K |
| D | 2025-03-05 | 2025-03-03 | ELV | Elevance Health | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +3,604 | 23.6K | +18% | $0 |
| 2024-10-04 | 2024-10-02 | ELV | Elevance Health | Kaye Mark | EVP, CFO | F - Tax | $505.16 | -2,818 | 20.2K | -12% | -$1.42M | |
| D | 2024-03-05 | 2024-03-01 | ELV | Elevance Health | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +2,755 | 23.0K | +14% | $0 |
| DM | 2023-10-04 | 2023-10-02 | ELV | Elevance Health | Kaye Mark | EVP, CFO Designate | A - Grant | $0.00 | +20.3K | 18.2K | New | $0 |
| DM | 2023-08-08 | 2023-08-07 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | S - Sale+OE | $340.97 | -15.2K | 4,447 | -77% | -$5.17M |
| DM | 2023-08-08 | 2023-08-07 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | M - OptEx | $268.78 | +11.3K | 6,188 | New | +$3.04M |
| 2023-07-05 | 2023-07-03 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | F - Tax | $344.19 | -43 | 8,279 | -0.5% | -$14.8K | |
| 2023-05-22 | 2023-05-19 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | S - Sale | $317.91 | -975 | 8,322 | -10% | -$310.0K | |
| 2023-03-03 | 2023-03-01 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +5,537 | 12.7K | +77% | $0 | |
| 2023-03-03 | 2023-03-01 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | F - Tax | $290.63 | -3,426 | 9,297 | -27% | -$995.7K | |
| D | 2023-02-23 | 2023-02-21 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | A - Grant | $295.33 | +1,845 | 7,186 | +35% | +$544.9K |
| DM | 2022-08-16 | 2022-08-15 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | M - OptEx | $165.88 | +3,114 | 6,715 | +86% | +$516.6K |
| DM | 2022-08-16 | 2022-08-15 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | S - Sale+OE | $322.25 | -3,114 | 5,341 | -37% | -$1.00M |
| 2022-07-05 | 2022-07-01 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | F - Tax | $272.81 | -43 | 5,341 | -0.8% | -$11.7K | |
| 2022-03-03 | 2022-03-02 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | S - Sale | $325.24 | -3,702 | 5,384 | -41% | -$1.20M | |
| 2022-03-02 | 2022-03-01 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +7,285 | 13.5K | +118% | $0 | |
| 2022-03-02 | 2022-03-01 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | F - Tax | $323.88 | -4,379 | 9,086 | -33% | -$1.42M | |
| D | 2022-02-22 | 2022-02-17 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | A - Grant | $325.99 | +1,595 | 6,180 | +35% | +$520.0K |
| 2021-11-19 | 2021-11-18 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | S - Sale | $398.28 | -316 | 4,585 | -6% | -$125.9K | |
| DM | 2021-08-17 | 2021-08-16 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | M - OptEx | $279.85 | +2,090 | 5,257 | +66% | +$584.9K |
| DM | 2021-08-17 | 2021-08-16 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | S - Sale+OE | $379.69 | -3,133 | 4,901 | -39% | -$1.19M |
| A | 2021-08-09 | 2021-08-06 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | F - Tax | $363.42 | -45 | 5,944 | -0.8% | -$16.4K |
| 2021-07-02 | 2021-07-01 | MCO | Moody's Corporation | Kaye Mark | EVP, CFO | S - Sale | $363.42 | -43 | 5,946 | -0.7% | -$15.6K |
Purchase Sale Sale after option exercise All abbreviations